Tofacitinib Impurity 36
![Tofacitinib Impurity 36 Structure](CAS/20210305/GIF/2250241-69-9.gif)
- CAS No.
- 2250241-69-9
- Chemical Name:
- Tofacitinib Impurity 36
- Synonyms
- Tofacitinib Impurity 36;Tofacitinib Impurity 219;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one;7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one (Tofacitinib Impurity);4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-
- CBNumber:
- CB53166559
- Molecular Formula:
- C13H11N3O3S
- Molecular Weight:
- 289.31
- MOL File:
- 2250241-69-9.mol
Tofacitinib Impurity 36 Preparation Products And Raw materials
Raw materials
Preparation Products
Tofacitinib Impurity 36 Suppliers
Global( 22)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | China | 23556 | 58 | Inquiry |
China National Standard Pharmaceutical Corporation Limited | +8615391658522 | China | 11927 | 58 | Inquiry |
Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
Shanghai YuZn Pharm. Technology Co.,Ltd. | 15921286451; 15921286451 | China | 5063 | 58 | Inquiry |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 | China | 5000 | 58 | Inquiry |
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd | 18502726233; 18502726233 | China | 9486 | 58 | Inquiry |
Accela ChemBio Co.,Ltd. | 021-50795510 4000665055 | China | 11728 | 58 | Inquiry |
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 18102736234 18102736234 | China | 7100 | 58 | Inquiry |
Shanghai Haohong Scientific Co., Ltd. | 400-400-8210725 | China | 40041 | 58 | Inquiry |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 | China | 3620 | 58 | Inquiry |
2250241-69-9(Tofacitinib Impurity 36)Related Search:
Tofacitinib Impurity 2
Tofacitinib Impurity 45
Tofacitinib Related Compound
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Tofacitinib Impurity
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
chevron_left
1of4
chevron_right
Tofacitinib Impurity 36
Tofacitinib Impurity 219
7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one
4H-Pyrrolo[2,3-d]pyrimidin-4-one, 3,7-dihydro-7-[(4-methylphenyl)sulfonyl]-
7-Tosyl-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one (Tofacitinib Impurity)
2250241-69-9